Brief: Viking Global Investors Lp Reports 12.3% Passive Stake In Inhibrx Biosciences, Inc. As Of May 29, 2024- SEC Filing
07/06/2024 22:16
June 7 (Reuters) - Inhibrx Biosciences Inc INBX.O :
* VIKING GLOBAL INVESTORS LP REPORTS 12.3% PASSIVE STAKE IN
INHIBRX BIOSCIENCES, INC. AS OF MAY 29, 2024- SEC FILING
Source text for Eikon: ID:n0000905148-24-001689
Further company coverage: INBX.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Inhibrx Biosciences
See all newsInhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study (updated)
Inhibrx's combination cancer drug shrinks tumors in mid-stage head and neck cancer study
NASDAQ RESUMED AT 08:00 AM
Brief: Inhibrx's Inbrx-106 Nearly Doubles Response Rate And Achieves Interim Median Pfs Of 9.6 Months In Phase 2 Hnscc Study
NASDAQ TRADE HALT HALT NEWS PENDING AT 07:25 AM